The United States Department of Naval Medical Research Center (NMRC)
intends to make a sole source award to Vical Inc. for the production of novel DNA vaccines and participation with the Transformational Medical Therapeutics Program (TMT) of the Defense Threat Reduction Agency (DTRA) during upcoming excercises in FY2011 by providing proprietary products and processes. Viral and Rickettsial Diseases Department of the Naval Medical Research Center (NMRC/ VRDD). Vical have existing sole source contracts to produce novel DNA-Vaxfectin vaccines. See attached Sole Source Justification
For Other Than Full And Open Competition.
Bid Protests Not Available